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Abstract
Macrophages provide key elements of the host response to
influenza A virus (IAV) infection, including expression of type I
IFN and inflammatory cytokines and chemokines. TBK1 (TNF
receptor–associated factor family member–associated NF-kB
activator–binding kinase 1) contributes to IFN expression and antiviral
responses in some cell types, but its role in the innate response to IAV
in vivo is unknown. We hypothesized that macrophage TBK1
contributes to both IFN and non-IFN components of host defense and
IAV pathology. We generated myeloid-conditional TBK1 knockout
mice and assessed the in vitro and in vivo consequences of IAV
infection. Myeloid-specific loss of TBK1 in vivo resulted in less severe
host response to IAV, as assessed by decreased mortality, weight loss,
and hypoxia and less inflammatory changes in BAL fluid relative to
wild-type mice despite no differences in viral load. Mice lacking
myeloid TBK1 showed less recruitment of CD641SiglecF2Ly6Chi
inflammatory macrophages, less expression of inflammatory cytokines
in the BAL fluid, and less expression of both IFN regulatory factor
and NF-kB target genes in the lung. Analysis of sorted alveolar
macrophages, inflammatory macrophages, and lung interstitial
macrophages revealed that each subpopulation requires TBK1 for
distinct components of the response to IAV infection. Our findings
define roles for myeloid TBK1 in IAV-induced lung inflammation
apart from IFN type I expression and point to myeloid TBK1 as a
central and cell type–specific regulator of virus-induced lung damage.
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Clinical Relevance
Innate immune responses during influenza infection can
contribute to host tissue damage. The signaling pathways are
often amenable to modulation in therapeutically useful ways.
Macrophages are a major source of type I IFNs in viral
infections, and the kinase TBK1 (TNF receptor–associated
factor family member–associated NF-kB activator–binding
kinase 1) is critical in most cell types for expression of type I
IFN. This study defines additional, discrete, and unexpected
roles for TBK1 in the pathogenesis of influenza infection.
We show that mice lacking myeloid TBK1 have decreased
expression of inflammatory genes and impaired recruitment
of inflammatory macrophages to the lung in influenza
infection, leading to milder disease.
Influenza A virus (IAV) infection causes
significant mortality and morbidity
worldwide annually. IAV-induced lung
injury results from both viral killing of
infected cells and exuberant host immune
responses. The host response to IAV has
several components, including expression of
type I IFNs to restrict viral replication,
activation, and recruitment of local and
circulating immune cells; killing and
clearance of infected or dead cells; and
regeneration of injured epithelium.
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Antiviral therapies for IAV improve clinical
outcomes (1), but they must typically be
given early in infection. Although IAV
strains vary in pathogenicity, multiple
lines of evidence suggest that severity of
illness corresponds with the degree of host
response (2, 3). Thus, there remains a need
for host-targeted therapies that prevent
tissue damage and can be given after
infection is established.
IAV infection stimulates multiple
pattern recognition receptors (PRRs) in
both infected epithelium and responding
immune cells, including alveolar macrophages
(AMs) and recruited, bone marrow–derived
exudative, or inflammatory macrophages
(InfMs) (4–6). Mouse models show
that IAV components stimulate Toll-
like receptors (TLRs), including TLR3
and TLR7/8; cytosolic nucleic acid
sensors retinoic acid inducible gene I
(RIG-I), mitochondrial antiviral signaling
(MAVS), and DNA-dependent activator
of IFN regulatory factors (DAI);
and the inflammasome protein NLRP3
(NACHT, LRR, and PYD domains-
containing protein 3) (7). PRR stimulation
leads to activation of the IKK kinases
and the related TNF receptor–associated
factor family member–associated NF-kB
activator–binding kinase 1 (TBK1), leading
to phosphorylation of transcription factors
that include members of the NF-kB and
IFN regulatory factor (IRF) families
(reviewed in Reference 8). Genetic deletion
of PRRs or downstream signaling genes in
mice reveals surprising and sometimes
paradoxical phenotypes in virus- or IAV-
infected animals that do not correspond
with in vitro cell phenotypes (reviewed
in Reference 7). Although some innate
immune sensors are required, some are
redundant and contribute either to
inflammation or to feedback inhibition
of other pathways. TBK1 is a convergence
point of multiple IAV-driven processes,
and thus understanding its function in IAV
pathogenesis is useful for developing host-
directed therapies.
TBK1 was identified as a binding
protein for TNF receptor–associated factor
family member–associated NF-kB activator
(TANK) (9). In many cell types, TBK1
serves as the major kinase phosphorylating
IRF3 and IRF7 and thus is required for
expression of type I IFN (10, 11) and other
IRF3/7-dependent genes, such as IFN-
induced protein with tetratricopeptide
repeats 1 (IFIT1), MX dynamin-like
GTPase 1 (Mx1), and CXCL10. In some
contexts, TBK contributes to activation of
NF-kB p65/RelA and promotes expression
of primarily p65-dependent genes, such
as IL-6 and RANTES (regulated upon
activation, normal T cell expressed and
secreted) (12, 13), or genes that require
a combination of IRF and NF-kB.
Conventional deletion of TBK1 in C57BL/6
mice leads to embryonic lethality that is
TNF receptor (TNFR) dependent and can
be rescued by crossing into either TNFR-
null mice or the TNFR2-null Sv129
background (13–15). Cell type–specific
deletion in T cells, B cells, and dendritic
cells has shown that TBK1 also regulates
T-cell migration, NF-kB–dependent
immunoglobulin class switching, and gene
expression downstream of the type I IFN
receptor (16–18).
The in vivo functions of myeloid
TBK1 remain undefined. TBK1-deficient
bone marrow macrophages (BMMs)
from TBK1-knockout (TBK1-KO) Sv129
mice have impaired expression of IFN-
b and CCL5/RANTES when stimulated
in vitro, but these mice are paradoxically
hyperresponsive to intraperitoneal LPS
(13). Thus, TBK1 likely contributes to
host defense and IAV pathology in a
cell type–specific manner.
In this study, we examined the role
of myeloid TBK1 in influenza infection.
Conditional gene deletion demonstrates that
myeloid TBK1 is dispensable for viral
control but drives the recruitment of InfMs
to the infected lung. Mice lacking myeloid
TBK1 have less severe host response to
influenza. In vitro influenza infection elicits
different patterns of gene expression from
AMs compared with BMMs. In vivo
alveolar, interstitial, or monocyte-derived
inflammatory subpopulations of lung
macrophages have differing requirements
for TBK1 in expression of antiviral genes,
inflammatory cytokines, or chemokines.
We conclude that myeloid TBK1 contributes
to the inflammatory response to influenza
apart from its defined role in type I IFN
expression, pointing to a role for TBK1 in




C57BL/6 TBK1lox/lox mice were a kind gift
from Dr. Katherine Fitzgerald (University
of Massachusetts) and were crossed
with LysM-Cre mice from The Jackson
Laboratory (stock no. 004781). Colonies
were maintained at the University of
North Carolina at Chapel Hill. All
mouse lines were bred and housed in
ventilated cages in pathogen-free facilities.
Experiments involving animals were
conducted in accordance with the
recommendations made by the American
Association for Laboratory Animal Science.
Procedures were carried out using protocols
approved by the University of North
Carolina at Chapel Hill School of Medicine
Institutional Animal Care and Use
Committee.
Influenza Infections
Influenza A/PR/8/34 H1N1 from Charles
River (10100374) was titered on MDCK
(Madin-Darby canine kidney) cells
(19). Eight- to 16-week-old female mice
were anesthetized with tribromoethanol.
Virus diluted in PBS was administered
intranasally as a 53 105 egg-infective
dose in 40 ml. For studies of intratracheal
infections, mice were given a 3,000 egg-
infective dose in 40 ml (50% tissue
culture–infective dose [TCID50], 22).
BMMs or AMs were infected in vitro at
multiplicity of infection 1 in Dulbecco’s
modified Eagle medium supplemented with
1% BSA and 5 mg/ml TPCK (tosylamide-
L-phenylethyl-chloromethyl ketone)
trypsin (MilliporeSigma). After 1 hour,
the medium was replaced with infection
medium consisting of Dulbecco’s modified
Eagle medium with 0.15% BSA, 1% FCS,
penicillin-streptomycin, and 5 mg/ml
TPCK trypsin.
BAL Fluid Collection and Analysis
The lungs of killed mice were lavaged with 1
ml of PBS/2 mM EDTA. BAL cytokines
were measured by using the Bio-Plex Pro
Mouse Cytokine Group 1 Panel 23-Plex
on a Bio-Plex MagPix imager (both from
Bio-Rad Laboratories). Mouse IFN-b
and IFN-a ELISAs were obtained from
InvivoGen. BAL cell differentials and
protein concentrations were measured
as described elsewhere (20). Lactate
dehydrogenase assays were performed by
the University of North Carolina Animal
Histopathology and Lab Medicine Core.
Flow Cytometry and Cell Sorting
Lungs were digested to single-cell
suspensions by intratracheal instillation
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of 5 mg/ml collagenase I (Worthington
Biochemical Corp.) and 0.25 mg/ml DNase I
(MilliporeSigma) at 378C for 30 minutes,
followed by mechanical disruption, as
previously described (21). Details of
antibody staining are provided in the data
supplement. Cell sorting was performed
using a BD FACSAria II flow cytometer
(BD Biosciences).
Statistical Analysis and Graphics
Error bars represent the SEM. For RT-
qPCR, all samples were run in technical
(assay) triplicate or duplicate. For in vitro
ELISAs, all samples were run in assay
triplicate. All figures depict experiments
that have been replicated a minimum of
two times. For Kaplan-Meier survival
curves, significance was computed by
Gehan-Breslow-Wilcoxon test. ANOVA,
two-tailed unpaired t tests, and the Mann-
Whitney U tests were performed using
Prism software (GraphPad Software), and
the level of significance is indicated by
*P, 0.05, **P, 0.01, ***P, 0.005, and




TBK1 Impairs Macrophage Gene
Expression in a Stimulus-Specific
Manner
We generated myeloid-deficient TBK1 mice
by crossing TBK1fl/fl mice with LysM-Cre
mice that express Cre recombinase driven
by the lysozyme 2 promoter (16, 23).
RT-PCR of TBK1 mRNA shows that Cre
expression causes loss of TBK1 expression
from both lavageable AMs and BMMs
differentiated from LysM-Cre–expressing
TBK1fl/fl (M-TBK1-KO) mice that is
comparable to that in the well-characterized
TBK1-KO mouse embryonic fibroblast
line (Figure 1A). BMMs had undetectable
expression of TBK1 protein relative
to littermate TBK1fl/fl mice that lacked
LysM-Cre (wild type [WT]) (Figure 1B),
indicating that LysM-Cre can inactivate
floxed TBK1 alleles. In contrast, neutrophils
had no defect in Tbk1 mRNA expression
(data not shown). When stimulated
with LPS or polyinosinic:polycytidylic
acid [poly(I:C)], BMMs from M-TBK1-KO
mice had no defect in degradation of the
NF-kB inhibitor IkBa or phosphorylation
of p65 S536, but they did show impaired
phosphorylation of IRF3 S396 (Figure 1B).
Poly(I:C)-stimulated BMMs did show
impaired upregulation of ISG15 (IFN-
stimulated gene 15), which is driven by
both IRF3 and IFN-b. Similar to BMMs,
AMs from M-TBK1-KO mice showed
loss of TBK1 expression by Western
blot analysis (Figure 1D) and loss of
IRF3 phosphorylation but intact p65
phosphorylation when stimulated with LPS
or poly(I:C). TBK1 was required for ISG15
expression in poly(I:C)-stimulated AMs.
TBK1-deficient AMs showed upregulation
of IKKe (Figure 1D), perhaps reflecting a
compensatory pathway.
When stimulated with poly(I:C),
M-TBK1-KO BMMs showed decreased
expression of the mRNAs coding for IFN-
b1, CXCL10, Mx1, and CCL2 but largely
intact expression of TNF-a, RANTES, IL-
12A, and CCL20 mRNA relative to WT
controls (Figure 2A). LPS-stimulated M-
TBK1-KO BMMs showed less expression
of IFN-b1, TNF-a, RANTES, and IL-12A
mRNAs but unimpaired mRNA expression
of CCL2, CXCL10, Mx1, and CCL20
(Figure 2B). Mx1 is a commonly examined
ISG. Although many mouse strains,
including C57BL/6, carry a two-exon
deletion that renders the Mx1 protein
inactive and alters susceptibility to
influenza, transcription of Mx1 mRNA is
preserved and has been shown to reflect
IRF3 and NF-kB activation (24, 25). Similar
results were seen with IFIT1, another
commonly examined ISG (data not shown).
These results indicate that BMMs require
TBK1 for activation of IRF and NF-kB
targets in a stimulus-dependent manner,
which may reflect the relative contribution
of upstream MyD88 or TRIF (Toll/IL-1
receptor domain–containing adapter-
inducing IFN-b) to activation by each
stimulus.
M-TBK1-KO Mice Have a Less Severe
Host Response to Influenza
To examine the involvement of myeloid
TBK1 in the response to influenza, we
challenged M-TBK1-KO mice or their
Cre-WT littermates with IAV strain PR8
(TCID50, 366/mouse). Strikingly, M-TBK1-
KO mice had decreased and delayed
mortality after intranasal infection with
IAV (Figure 3A). M-TBK1-KO mice
initially lost weight similarly to WT
littermates, but from approximately Day 7
after infection, they exhibited less severe
weight loss and began to recover earlier
(Figure 3B). M-TBK1-KO mice also
exhibited decreased mortality and
weight loss when PR8 was administered
intratracheally (Figures E1A and E1B in the
data supplement). When viral load was
assessed by RT-qPCR of the IAV M2 gene
from lung homogenates, no difference was
observed between Days 2 and 14 after either
intranasal or intratracheal inoculation
(Figures 3C, E1C, and E1D). Viral load
assessed by TCID50 of lung homogenates at
Day 6 likewise did not differ between WT
and M-TBK1-KO mice (Figure 3D). At 6
days after intranasal infection, M-TBK1-
KO mice had better oxygenation and no
differences in heart rate or respiratory rate
(Figures 3E–3G). These results suggest that
M-TBK1-KO mice have a less clinically
severe response to influenza infection that
is significant by Day 6.
M-TBK1-KO Have Less Inflammatory
Changes in BAL Fluid after Influenza
Infection
We also examined markers of lung
inflammation within the alveolar space,
including BAL fluid protein and leukocytes.
Although WT mice accumulated BAL fluid
protein that peaked around Day 6, indicative
of lung injury, M-TBK1-KO mice had
a slower and smaller accumulation of
BAL fluid protein (Figure 3H). There
was a strong trend toward less lactate
dehydrogenase in the BAL fluid (P = 0.06)
Figure 3I). Cytospin counts of BAL fluid at
Day 6 showed fewer lavageable neutrophils
and no difference in macrophage or
lymphocyte counts in M-TBK1-KO
compared with WT mice (Figures 3J and
3K). Taken together, these data suggest
that intraalveolar and luminal airway
inflammation is less at the peak of lung
inflammation in M-TBK1-KO mice than
in WT mice.




To examine the abundance of immune cells
in the lung at after influenza infection,
influenza-infected mouse lungs were
digested to single-cell suspensions and
analyzed by flow cytometry. The leukocytes
were identified as CD451 cells, and markers
for macrophages, neutrophils, natural killer
(NK) cells, and T cells were included in
the immunopanel (gating strategy in Figure
E2). The CD641Ly6G2 lung macrophage
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population was gated to identify
macrophage subpopulations of AMs
(SiglecF1Ly6C2/low), interstitial macrophages
(IMs) (SiglecF2Ly6C2), and recruited
InfMs (SiglecF2Ly6C1) (Figure 4A). At
Days 4 and 6 after infection, the number
of CD641Ly6G2 SiglecF2Ly6C1 InfMs
was strikingly less in M-TBK1-KO mice
(Figures 4B and 4C). The numbers of
AMs and IMs were similar in WT and
M-TBK1-KO mice, suggesting that loss
of TBK1 does not alter survival or apoptosis
of these macrophage subpopulations
during influenza. M-TBK1-KO mice
showed no change in the numbers of
CD41, CD81, and gDT cells and no
significant difference in the number of
neutrophils or NK cells in the lungs
(Figures 4B and 4C). Likewise,
immunophenotyping of circulating and
splenic cells from uninfected WT and M-
TBK1-KO mice showed no differences
(Figure E3). When BAL populations were
examined, no difference in lavageable AM,
IM, or InfM numbers was observed at Day
6 (Figure 4D); of note, we observed far
fewer InfMs in BAL fluid than in lung
digests during pneumonia. These results
suggest that myeloid TBK1 is required for
the recruitment of InfMs from the blood
and bone marrow to the lung parenchyma
but not for the recruitment, proliferation, or
survival of other macrophage subpopulations,
T cells, or NK cells.
M-TBK1-KO Mice Have Less Lung
Inflammatory Gene Expression and
Lower BAL Cytokine Levels
To examine lung inflammation, we
measured gene expression by RT-qPCR of
whole-lung homogenates from influenza-
infected mice starting at Day 2 and
extending through Day 14 after infection,
at which time the mice have cleared the
infection and are in the process of resolving
the lung injury. M-TBK1-KO mice had
lower levels of CXCL10 mRNA and a trend
toward less IFN-b1 mRNA at Day 6,
whereas IFN-a4 was only weakly induced
and not impaired in M-TBK1-KO mice
(Figure 5A). M-TBK1-KO mice had
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C
Figure 1. Myeloid-specific deletion of TNF receptor–associated factor family member–associated NF-kB activator–binding kinase 1 (TBK1)
impairs IFN regulatory factor 3 (IRF3) phosphorylation in macrophages. (A) RT-qPCR of TBK1 mRNA from mouse embryonic fibroblasts, bone
marrow macrophages (BMMs), and BAL macrophages. Error bars represent technical triplicates, and data are representative of two independent
experiments. (B) Immunoblots of BMMs from wild-type (WT; LysM-Cre2, TBK1flox/flox) or TBK1-knockout (M-TBK1-KO; LysM-Cre1, TBK1flox/flox)
mice stimulated in vitro with 100 ng/ml LPS or 25 mg/ml polyinosinic:polycytidylic acid [poly(I:C)] for the indicated times. (C) Immunoblots of
alveolar macrophages from WT or M-TBK1-KO mice stimulated in vitro with the same concentrations of LPS or poly(I:C). (D) Immunoblots
of alveolar macrophages from WT or multiple M-TBK1-KO mice. Immunoblots are representative of at least two independent experiments.
AM = alveolar macrophage; H3 = histone H3; ISG15 = IFN-stimulated gene 15; US = unstimulated.
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and IL-12A mRNA at Day 6, whereas
IL-6 mRNA expression was unimpaired
in KO mice (Figure 5B). M-TBK1-KO
mice had less CCL2/monocyte
chemoattractant protein 1 (MCP1) and
CCL5/RANTES mRNA and a trend toward
less CCL3/macrophage inflammatory
protein-1a (MIP-1a) at Day 6 (Figure 5C).
To examine lung inflammation, type I
IFN and cytokine expression in BAL fluid
from M-TBK1-KO and WT mice at 6 days
after infection was measured using
multiplex ELISAs. Type I IFNs were
expressed at low levels in BAL fluid, and
neither IFN-a nor IFN-b was significantly
less at Day 3 or Day 6 after infection in
M-TBK1-KO mice (Figures 6 and E5),
suggesting that myeloid TBK1 is not
required for secretion of type I IFN into the
airspace at these times, in agreement with
the mRNAs. In comparison, significant
differences in multiple BAL cytokines were
identified between genotypes. M-TBK1-KO
mice expressed lower levels of TNF-a,
GM-CSF (granulocyte–macrophage
colony–stimulating factor), and IL-12
p70 (Figure 6) with trends toward
less expression of KC (keratinocyte
chemoattractant). BAL levels of RANTES,
IL-6, and MIP-1a/b were largely intact.
Taken together, these results suggest that
myeloid TBK1 contributes to expression
of certain inflammatory cytokines in
the lung, either directly through gene
expression or indirectly by altering the
abundance of inflammatory cells in the
lung and airspace.
TBK1 Deletion Impairs BMM and AM
Transcriptional Responses Differently
during Influenza Infection In Vitro
Our in vivo studies show that M-TBK1-KO
mice show no change in AM number but a
large defect in recruitment of InfMs, which




















































































































US pIC 1h pIC 4h
TNF































































































































































































Figure 2. Myeloid deletion of TBK1 impairs expression of IRF and NF-kB target genes. RT-qPCR was used to assess mRNA of indicated genes from
BMMs stimulated with (A) LPS or (B) polyinosinic:polycytidylic acid (pIC) for the indicated times. Data are normalized to the 18S mRNA, expressed as fold
change compared with uninfected WT mice by comparative cycle threshold method, and compared by two-tailed unpaired t test. n = 3 per group and
least two independent experiments. *P , 0.05, **P , 0.01, and ***P , 0.005. NS = not significant; RANTES = regulated upon activation, normal T cell
expressed and secreted.
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AMs and BM-derived monocytes and
macrophages are noted to play different
roles in influenza infection (5, 26). We
assessed the role of TBK1 in their
transcriptional response to influenza
infection using the H1N1 PR8 strain
in vitro. In response to IAV infection for 6
hours, lavageable AMs from M-TBK1-KO
mice showed a pronounced defect in
expression of mRNAs coding for IFN-b1,
Mx1, and CXCL10 mRNA and a trend
toward decreased CCL2 (Figures 7A and
E6) but largely intact expression of CCL3,
CCL4, CCL5, and TNF-a. In contrast,
BMMs from M-TBK1-KO mice had intact
induction of IFN-b1, Mx1, and CXCL10
mRNA but impaired expression of CCL3
and CCL4 and elevated expression of IL-6
(Figures 7B and E6). Complementary
results were seen by ELISA (Figure E4A).
Notably, BMMs transcriptionally upregulate
TBK1 at least twofold when infected
with IAV, whereas AMs do not (Figure
E4B). These results indicate that AMs and
BMMs respond differently upon encountering
influenza virus.
To determine how macrophage
subpopulations contribute to TBK1-
dependent gene expression in vivo, we
isolated AMs, IMs, and InfMs from lung
digests using FACS at Day 4 after infection
Although AMs are numerically depleted
at this time, they appear to be the major
0.0
























































































































































































Figure 3. M-TBK1 KO mice have a less severe host response to influenza than WT mice. (A) Survival and (B) weight curves for mice infected intranasally with
53 104 egg-infective dose (tissue culture–infective dose [TCID50], 366) of influenza A virus (IAV) strain PR8. Mortality was assessed by Gehan-Breslow-Wilcoxon
test and weight by two-way ANOVA with multiple comparisons (Šidák correction). (C) Viral infection level as measured by RT-qPCR of IAV M2 gene from lung
homogenates at Days 1–14. (D) Viral infection level as measured by TCID50 from lung homogenates at Day 6. (E) Arterial oxygen saturation, (F) heart rate, and (G)
respiratory rate at Days 0 and 6. n=3–8 mice per group in two independent experiments. (H) BAL fluid (BALF) protein measurements frommice at Days 0–14 after
infection. (I) Lactate dehydrogenase (LDH) measurements in BALF from mice at Day 6. (J) Leukocyte counts in BALF assessed using cell counts and cytospins on
Day 6. (K) Representative cytospin images from BAL at Day 6. Panels H–J depict six to eight mice per group and two or three independent experiments. Panels
D–J reflect analysis by two-tailed unpaired t test. *P , 0.05, **P , 0.01, and ***P , 0.005. ActB =b-actin; U =units.
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macrophage producers of TNF-a and
CCL3 (Figures 7C and E7), which both
require TBK1 for full expression. In
contrast, IMs are major producers of
TBK1-dependent IL-6 and IFN-b1 at this
time, whereas InfMs are major producers of
TBK1-dependent CXCL10 and Mx1. These
data show that that these macrophage
subpopulations have differing requirements
for TBK1 in antiviral and inflammatory
gene expression. They also demonstrate
that the in vivo gene expression patterns of
macrophage subpopulations are not well
reflected by either AMs or BMMs infected
in vitro.
Discussion
In the present study, we examined the role of
myeloid TBK1 in influenza infection. We
observed that myeloid deletion of TBK1
results in decreased mortality and weight
loss in influenza-infected mice without
altering the level of viral infection. These
results implicate myeloid TBK1 in the
inflammatory lung injury that can
accompany severe influenza infection.
We observed no difference in the level of
virus or viral genome between WT and
M-TBK1-KO mice, suggesting that
infectivity, viral replication, and viral
clearance are not obviously dependent on
myeloid TBK1. These data also suggest that
viral load is not the primary driver of the
morbidity or mortality. Although the
decreased disease severity in M-TBK1-KO
mice is surprising, other mouse models
support the idea that targeting innate
immune pathways can decrease host
injury without compromising viral control.
Mice with conventional deletion of TLR7,
TLR3, and MyD88 have decreased
influenza-related mortality and pathology
(reviewed in Reference 7). In comparison,
deletion of other components, such as
IFNAR, IKKe, or PKR, or combined
deletion of MyD88/TRIF or TLR3/TLR7
increases mortality and morbidity. This
may reflect either protein-specific
functions or the fact that inflammation
and injury represent the summation of
many pathways acting simultaneously.
Most strikingly, we noted a marked
decrease in the number of recruited
CD641SiglecF2Ly6C1 InfMs in the
lungs of M-TBK1-KO mice (Figure 4)
during the peak of lung injury, despite no
significant alteration in expression of
monocyte-attracting chemokines such as
MCP1/CCL2. InfMs are known to be
major producers of CXCL10 (27), and
consistent with this, we observed
decreased lung CXCL10 in M-TBK1-KO
mice. Multiple lines of evidence implicate
recruited InfMs in the severity of influenza
lung injury in both humans and mice (26,
28–30). Recruited mouse InfMs may
derive from one or more monocyte pools,
including the CCR21, CX3CR11, or
intermediate monocyte pools (31). Further
studies will be required to delineate
whether TBK1 is required in some or all
monocyte populations. Taken together,
these observations point to a role for
myeloid TBK1 in promoting the
recruitment of bone marrow–derived
InfMs into the lung during influenza
infection.
Measurement of gene expression
from lungs of infected WT and M-TBK1-
KO mice showed alterations in multiple
genes, including TNFa, CCL2, CCL5,
and CXCL10, with trends toward
impaired expression of IFN-b1 and CCL3.
When we examined sorted macrophage
subpopulations from infected WT and
M-TBK1-KO mice, we saw that TBK1
functioned differently in different lung
macrophages. AMs appeared to be a major
source of TNF-a and CCL3 at Day 4 after
infection and required TBK1 for full
expression, whereas IMs were a major
source of IL-6, IFN-b1, and CCL5,
for which they required TBK1. In
comparison, InfMs produced abundant
CXCL10 and CCL4 in a TBK1-dependent
manner. These data suggest that the
M-TBK1-KO phenotype of decreased lung
inflammatory gene expression includes
specific contributions of TBK1 in multiple
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Figure 4. M-TBK1-KO mice have fewer recruited inflammatory lung macrophages during influenza
infection. Mice were infected intranasally with 53 104 egg-infective dose and lungs were harvested
and digested to single-cell suspensions. (A) Representative flow cytometric plot from
CD451/Ly6G2/CD641 gate showing definition of resident alveolar (AM; Siglec F1/Ly6Clow), resident
interstitial (IM; Siglec F2/Ly6C2), and recruited inflammatory (InfM; Siglec F2/Ly6C1) macrophages.
Total number of relevant cell populations identified by flow cytometry at (B) Day 4 and (C) Day 6 after
infection. (D) Macrophage subpopulations recovered from BAL at Day 6 after infection. n = 6–8 mice
per genotype per group and two independent experiments analyzed by Mann-Whitney U test. NK =
natural killer cells. ****P , 0.001. gd = gd.
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macrophage subpopulations. In addition,
some TBK1-dependent gene and cytokine
expression in IAV infection may derive
from non-IAV danger signals that activate
TBK1, such as hyaluronan and self-DNA
from dying cells (32, 33), and these signals
may contribute to differences in mRNAs
that require TBK1 only under certain
circumstances, such as TNF-a, IL-12A, and
CCL5 (Figures 2 and 5–7). M-TBK1-KO
mice have preserved numbers of lung
neutrophils in lung digests but fewer
lavageable neutrophils in the alveolar space.
The production of lower levels of cytokines
and neutrophil chemokines, including
TNF-a and KC, suggests that this is the
reason for decreased recruitment to the
alveolar space. Although LysM-Cre targets
all myeloid cells, we observed intact
expression of TBK1 mRNA in the
lavageable neutrophils of M-TBK1-KO
mice (data not shown), suggesting that
the defect in recruitment is likely due to less
production of inflammatory mediators
rather than to a defect in recognition,
adhesion, and migration by neutrophils.
Of note, we observed only a modest
reduction in the level of type I IFN protein
and mRNA in the lung across the course of
infection (Figures 5 and 6A), suggesting
that myeloid TBK1 is largely dispensable
for type I IFN in this setting. This may
reflect compensation by IKKe, which we
observed to be upregulated in TBK1-KO
AMs (Figure 1C) or by other kinases, such



































































































































































































































Figure 5. M-TBK1-KO mice have less lung inflammatory gene expression. RT-qPCR of indicated mRNAs from lung homogenates. Commonly examined
(A) IRF3 targets, (B) NF-kB targets, and (C) chemokines are shown. Lungs from intranasally infected mice were snap frozen, and mRNA and cDNA were
prepared. Data are normalized to 18S mRNA and expressed as fold change compared with an average of Day 0 mice. n = 5–8 mice per point and
two independent experiments analyzed by Mann-Whitney U test. *P , 0.05 and **P , 0.01. MCP1 =monocyte chemoattractant protein 1; MIP1a =
macrophage inflammatory protein 1a.
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such as respiratory epithelium contribute
significantly to type I IFN expression.
These studies show that LysM-
Cre–induced deletion of Tbk1 results in
complete loss of TBK1 protein in both
BMMs and AMs. This depletion effectively
mimics changes seen in macrophages from
conventional TBK1/Tnfsfr1a-KO mice
(14) and Sv129 TBK1-KO mice that lack
Tnfrsf1b (TNF receptor superfamily
member 1B) (13). M-TBK1-KO AMs and
BMMs infected with IAV in vitro
displayed complementary transcriptional
defects; TBK1-null AMs are strongly
impaired in expression of IFN-b1 and
ISGs such as Mx1 and CXCL10, whereas
TBK1-null BMMs express IFN-b1, Mx1,
and CXCL10 in the setting of IAV but
have impaired expression of genes such
as CCL3 and CCL4 (Figure 7). We
propose that TBK1 has macrophage
subpopulation–specific contributions
to IRF and NF-kB activation. This
may be mediated either by cell
type–specific expression of TBK1
adaptor proteins (TANK, OPTN
[optineurin], Azi2 [5-azacytidine–
induced protein 2]), alterations in
TBK1-activating scaffolds such as TRAF
(TNF receptor–associated factor) family
members and STING (stimulator of
IFN genes), or some other mechanism.
Activation of TBK1 by hyperactivating
STING mutations results in elevated






































































Figure 6. M-TBK1-KO mice have less BAL cytokine expression. ELISA of indicated cytokines and
chemokines from BAL fluid of infected mouse lungs harvested at Day 6 after infection. n = 3–8 mice
per point and two separate experiments analyzed by Mann-Whitney U test. *P , 0.05. GM-CSF =
granulocyte–macrophage colony–stimulating factor; KC = keratinocyte chemoattractant.
B








































Figure 7. TBK1 deletion impairs BMM and AM transcriptional responses differently during influenza virus infection in vitro and has subtype-specific effects
on lung macrophages in vivo. RT-qPCR of (A) AMs or (B) BMMs infected with multiplicity of infection 1 of IAV strain PR8 in vitro for 6 hours. Data were
normalized to the 18S mRNA and expressed as fold change compared with uninfected WT by the comparative cycle threshold method. Heatmap depicts
z-score of mRNA transcript expression level scaled to row mean. n = 3 per group and two independent experiments. Asterisks depict significance of
P values for infected WT versus TBK1-KO samples (*P, 0.05, **P, 0.01, ***P, 0.005, and ****P, 0.001). More detailed graphs for each gene are shown
in Figure E6 in the data supplement. (C) Macrophage subpopulations were isolated from lung digests using FACS at Day 4 after infection and subjected to
RT-qPCR of indicated genes. mRNA levels were normalized to ActB or to 18S by the comparative cycle threshold method. Data reflect three pooled mice
analyzed in technical triplicate. All rows attain statistical significance by two-way ANOVA. Symbols depict significance (P, 0.05) by Šidák’s multiple
comparisons method between WT and KO for AMs#, IMs‡, or InfMsw. Detailed graphs for each gene are shown in Figure E7.
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cytokines, including TNF-a, MCP1, MIP-
1a/b, and G-CSF (granulocyte colony-
stimulating factor) (35), and this effect
persists when IRF3 is deleted, further
implicating TBK1 as a driver in
inflammation independent of the IRF axis.
We observed that TBK1 contributed to
the expression of classical IRF targets
(such as IFN-b, Mx1, and IFIT1), classical
NF-kB targets (such as TNF-a), and genes
that are driven by a combination of
transcription factors. The detailed TBK1-
dependent signaling pathways that each
macrophage subpopulation uses to
perform diverse functions remain to
be defined.
In summary, we demonstrate that
myeloid TBK1 contributes to morbidity and
mortality in influenza-infected mice and is
largely dispensable for viral control. Mice
lacking myeloid TBK1 have decreased
numbers of InfMs at the peak of infection
and injury, pointing to a role for myeloid
TBK1 in promoting the generation and
recruitment of bone marrow–derived
InfMs. TBK1 promotes differing patterns
of inflammatory gene expression in lung
macrophage subtypes. TBK1 inhibition by
small-molecule inhibitors may be a point of
intervention in late or established severe
influenza infection. n
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